Detailed Narrative
Q3 FY26 Financial Performance Overview
Aether Industri. reported strong financial performance for Q3 FY26, with consolidated revenue from operations increasing by 44% YoY to INR3,171 million. EBITDA saw a significant 75% YoY growth, reaching INR1,083 million, and the EBITDA margin expanded to 34% from 28% in Q3 FY25. Net profit after tax (PAT) also grew by 49% YoY to INR645 million, resulting in a PAT margin of 20% for the quarter. For the nine months ended December 31, 2025, revenue increased 43% to INR8,534 million, EBITDA grew 75% to INR2,716 million, and PAT rose 53% to INR1,655 million.
Capacity Expansion and Commercialization Progress
The company announced the completion of construction and installation for Site 3++ and the first two production blocks of Site 5. Water and solvent trials have commenced, with commercial production from these sites expected to begin shortly, specifically from March 2026. The total CWIP for Site 3++ and Site 5 amounted to approximately INR500 crores in the first nine months of FY26. For FY27, Site 3++ is targeted for 45-50% capacity utilization, while the two blocks of Site 5 are expected to achieve 35-40% utilization.
Business Vertical Performance and Outlook
In Q3 FY26, sales composition included 43% from contracts plus exclusive manufacturing, 41% from large-scale manufacturing, and 8% from contract research and manufacturing services. Large-scale manufacturing demonstrated robust volume growth of over 10% QoQ and 25% YoY. Sales from Site 4 increased 20% QoQ to INR60 crores. The company expects the share of Oil and Gas (22%) and Material Science (18%) sectors to scale up by year-end, with a long-term target of 70% revenue from CRAMS/CEM and 30% from large-scale manufacturing.
R&D and New Client Initiatives
Aether is undertaking significant R&D expansion, including adding 20 fume hoods and engineering labs in the short term, and 15 additional labs with 150 fume hoods and advanced analytical equipment like NMR in the long term. This expansion focuses on chemical engineering for non-pharma, non-agro, oil and gas, and material science sectors. The company has secured a CEM exclusive contract with a European chemical company in the material science sector, which will utilize a modified production line in Site 3. Validation batches for electronic chemicals for the semiconductor industry, targeting Japan, South Korea, and Taiwan, have already been dispatched.
Working Capital and Margin Management
The net working capital cycle increased to 160 days in Q3 FY26 from 149 days as of September 30, 2025. This increase is primarily attributed to inventory buildup in preparation for the commercial launch of Site 3++ and Site 5 in March 2026. Management maintains a conservative sustainable EBITDA margin guidance of 29-30%, noting that the reported 34% margin in Q3 FY26 was partially influenced by a one-time📎 FLOP claim of INR15 crores.
Strategic Partnerships and Outsourcing Advantages
Management emphasized its strategy of building long-term strategic partnerships, particularly in the CEM segment, where it aims to be a 'go-to partner' and 'one-stop solution' for innovators. The company highlighted its competitive edge due to favorable Indian economics compared to the West, transparent costing models, and a commitment to long-term relationships (20 years, 10 projects in pipeline). Aether's focus on IP protection, trust, and executional innovation, coupled with redundant and fungible manufacturing sites, allows it to be a sole supplier for key clients like Baker Hughes.